naa a22 4500 510760236 CHVBK 20180411083136.0 cr unu---uuuuu 180411e20130201xx s 000 0 eng 10.1007/s11420-012-9316-6 doi (NATIONALLICENCE)springer-10.1007/s11420-012-9316-6 Predictors of Success of Corticosteroid Injection for the Management of Rotator Cuff Disease [Elektronische Daten] [Fernando Contreras, Haydée Brown, Robert Marx] Background: The use of subacromial corticosteroid injection (CSI) to treat rotator cuff tendinopathy is controversial. We hypothesized that characteristics such as activity level, American Shoulder and Elbow Surgeons (ASES) score, duration of symptoms, and status of the rotator cuff may be prognostic factors for resolution of symptoms postinjection. Methods: During a 12-month period, consecutive patients with rotator cuff disease were analyzed. Patients received subacromial CSI, oral NSAIDs, and physical therapy. Baseline ASES score, simple shoulder test, an activity scale, and demographic data were recorded. Patients who remained symptomatic and were indicated for surgery were considered failures. Patients that did not undergo surgery were reassessed after a minimum of 1year. Results: Forty-nine patients met our criteria. Follow-up was obtained for 81.6%. Sixteen cases (40%) failed conservative treatment at final follow-up (22.4 ± 11months). CSI were successful in 76.2% of males and 45% of females (p = 0.04). Full-thickness tears were present in 8% of the patients with symptom resolution and 25% of those that failed conservative treatment (p = 0.29). No significant difference was found in age, hand dominance, duration of symptoms, or any of the scoring systems. Conclusion: It is difficult to predict outcomes after CSI. Our treatment strategy showed a 40% failure rate. Hospital for Special Surgery, 2012 rotator cuff disease nationallicence rotator cuff tendinopathy nationallicence subacromial injection nationallicence corticosteroid injection nationallicence subacromial corticosteroid injection nationallicence subacromial impingement nationallicence shoulder pain nationallicence conservative treatment nationallicence nonoperative treatment nationallicence Contreras Fernando Hospital for Special Surgery, 535 East 70th Street, 10021, New York, NY, USA aut Brown Haydée Hospital for Special Surgery, 535 East 70th Street, 10021, New York, NY, USA aut Marx Robert Hospital for Special Surgery, 535 East 70th Street, 10021, New York, NY, USA aut HSS Journal ® Springer-Verlag 9/1(2013-02-01), 2-5 1556-3316 9:1<2 2013 9 11420 https://doi.org/10.1007/s11420-012-9316-6 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11420-012-9316-6 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Contreras Fernando Hospital for Special Surgery, 535 East 70th Street, 10021, New York, NY, USA aut NATIONALLICENCE 700 1- Brown Haydée Hospital for Special Surgery, 535 East 70th Street, 10021, New York, NY, USA aut NATIONALLICENCE 700 1- Marx Robert Hospital for Special Surgery, 535 East 70th Street, 10021, New York, NY, USA aut NATIONALLICENCE 773 0- HSS Journal ® Springer-Verlag 9/1(2013-02-01), 2-5 1556-3316 9:1<2 2013 9 11420 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer